Literature DB >> 19432899

Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.

Bostjan Humar1, Parry Guilford.   

Abstract

Hereditary diffuse gastric cancer is a cancer syndrome caused by germline mutations in the gene for the cell adhesion protein E-cadherin (CDH1). E-cadherin plays a central role in the maintenance of cell polarity and its loss during tumorigenesis is associated with poorly differentiated cancers and a poor prognosis. Hereditary diffuse gastric cancer is dominated by diffuse-type gastric adenocarcinoma, often with signet ring cell morphology. Large numbers of stage T1a signet ring cell carcinomas exist in the stomachs of CDH1 mutation carriers from a young age, and these foci sometimes show enrichment to the transition zone between the body and antrum. Generally these signet ring cell carcinomas are hypoproliferative, lack Wnt pathway activation, and are relatively indolent. However, a small proportion of the T1a foci contain cells that are poorly differentiated, display mesenchymal features, and express activated c-Src and its downstream targets. These same features are observed in more advanced stages of hereditary diffuse gastric cancer progression, suggesting that an epithelial-mesenchymal transition is required for tumor invasion beyond the muscularis mucosae. Hereditary diffuse gastric cancer initiation requires somatic down-regulation of the second CDH1 allele, which in most cases is caused by DNA promoter hypermethylation. Subsequent to CDH1 down-regulation, lost polarity in gastric stem or progenitor cells would be predicted to interfere with mitotic spindle orientation and the segregation of cell fate determinants. We predict that this disruption of cell division results in daughter cells being deposited in the lamina propria where their population expands and partially differentiates, resulting in the formation of foci of signet ring cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432899     DOI: 10.1111/j.1349-7006.2009.01163.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  32 in total

1.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 2.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

3.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

4.  Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.

Authors:  Irma Kluijt; Rolf H Sijmons; Nicoline Hoogerbrugge; John T Plukker; Daphne de Jong; J Han van Krieken; Richard van Hillegersberg; Marjolijn Ligtenberg; Eveline Bleiker; Anemieke Cats
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 5.  DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Ajay Goel
Journal:  Biochem Biophys Res Commun       Date:  2014-08-13       Impact factor: 3.575

6.  Cancer-stromal interactions in scirrhous gastric carcinoma.

Authors:  Masakazu Yashiro; Kosei Hirakawa
Journal:  Cancer Microenviron       Date:  2010-01-26

Review 7.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

Review 8.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

9.  Helicobacter pylori Infection and Gastric Adenocarcinoma.

Authors:  Pelayo Correa; M Blanca Piazuelo
Journal:  US Gastroenterol Hepatol Rev       Date:  2011-06

Review 10.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.